Every time an AI alert is sent,Ringpu Bio (SZ 300119, closing price: 19.36 yuan) released its annual performance report on the evening of March 25, saying that the operating income in 2021 will be about 2.007 billion yuan, an increase of 0.34% year-on-year; the net profit attributable to shareholders of the listed company is about 413 million yuan Yuan, a year-on-year increase of 3.66%; basic earnings per share was 1.0258 yuan, a year-on-year increase of 2.02%.
The chairman and general manager of Ripu Biosciences are Li Shoujun, male, 59 years old, with a Ph.D.
1. In the past 30 days, Ripple Bio has increased its northbound capital holdings by 556,900 shares, accounting for an increase of 0.22% in the proportion of tradable shares;
2. In the past 30 days, no institution has conducted research on Ripple Bio.
(Reporter Wang Xiaobo)
Disclaimer: The content and data in this article are for reference only and do not constitute investment advice. Please verify before use. Do so at your own risk.
Copyright Notice
1This article is an original work of “Daily Economic News”.
2
Without the authorization of “Daily Economic News”, it may not be used in any way, including but not limited to reprinting, excerpting, copying or creating mirror images, etc. Violators will be held accountable.
3Copyright cooperation telephone: 021-60900099.